HWAM
GENE

Hennion & Walsh Asset Management’s Genetic Technologies Ltd. GENE Stock Holding History

Hennion & Walsh Asset Management’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,188
Closed -$21K – 815
2021
Q4 		$21K Buy
+2,188
New +$28K ﹤0.01% 741
2021
Q3 		– Sell
-2,192
Closed -$47K – 770
2021
Q2 		$47K Buy
2,192
+178
+9% +$3.59K ﹤0.01% 723
2021
Q1 		$42K Buy
+2,014
New +$46.1K ﹤0.01% 692

Other funds holding GENE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Hennion & Walsh Asset Management's GENE Position: Q1 2022 in Review

Hennion & Walsh Asset Management sold out of Genetic Technologies Ltd. (GENE) in Q1 2022, closing a stake of 2,188 shares — an estimated $21K sold.

Hennion & Walsh Asset Management first reported a position in GENE in Q1 2021 and held it in 3 quarters. The position peaked at $47K in Q2 2021. 12 funds tracked by Wall St. Rank hold GENE as of Q1 2022.

  • Hennion & Walsh Asset Management reported no remaining Genetic Technologies Ltd. position as of Q1 2022 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 2,188 Genetic Technologies Ltd. shares in Q1 2022, an estimated $21K.
  • Hennion & Walsh Asset Management first reported a position in Genetic Technologies Ltd. in Q1 2021 and held it in 3 quarters.
  • Hennion & Walsh Asset Management's Genetic Technologies Ltd. position peaked at $47K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q1 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q1 2022, filed 26 Apr 2022.